Ruch Joshua, an insider at GeneDx Holdings Corp (WGS), sold 120,811 shares of the company's stock on November 23, 2025, at a price of $161.16 per share. The total transaction value reached $19.47 million. Following this sale, Joshua retains 120,811 shares in GeneDx.
GeneDx Holdings Corp operates as a health intelligence company, headquartered in Stamford, Connecticut, with approximately 1,000 full-time employees. The firm focuses on exome and genome testing to provide clinical insights that enhance personalized health plans and accelerate drug discovery. The company went public on September 4, 2020, and has a current market capitalisation of $4.0 billion. As of November 18, 2025, the company reported a P/E ratio of 1,922.81 and an EPS of 0.06.
Insider selling can occur for various reasons, including diversification, tax planning, or personal financial needs. While significant selling activity may attract scrutiny, routine transactions do not necessarily imply negative sentiment towards the company. Investors are advised to consider insider transactions as part of a broader analysis that includes multiple insiders and various time periods.
Such decisions reflect individual circumstances and regulatory obligations, rather than definitive indicators of company performance. The upcoming earnings report is scheduled for July 27, 2026, with an estimated EPS of $0.04 and projected revenue of $125.7 million, which investors may find relevant in their assessments of GeneDx's future prospects.